Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Basic Science Article
  • Published:

Quantitative plasma proteomic analysis in children after superior cavopulmonary anastomosis with pulmonary arteriovenous malformations

Abstract

Approximately 1000 children are born every year in the United States with one effective cardiac pumping chamber, or single ventricle heart disease. One of the early causes of mortality in this population is pulmonary arteriovenous malformations (PAVMs), which allow blood to bypass gas exchange in the lungs. PAVMs most frequently occur in children after superior cavopulmonary anastomosis (SCPA), a procedure that redirects venous blood from the upper body to the lungs. Because plasma proteins are in part responsible for directing angiogenesis, we hypothesized that differential protein concentrations would be observed in superior caval blood among children after SCPA according to PAVM status. We performed quantitative plasma proteomics from 11 children with PAVMs and in seven children without PAVMs; an additional 11 children with Fontan circulation were included as a reference. Among children with SCPA, there were no significant differences in the plasma proteomes for those with and without PAVMs. When comparing children with Fontan circulation to those with SCPA and PAVMs, 18 proteins exhibited differential expression (10 downregulated and eight upregulated) in superior caval plasma. These results suggest that factors other than, or in addition to, plasma proteins may be responsible for single ventricle patients’ susceptibility to PAVMs after SCPA.

Impact

  • What is the key message of your article? We did not identify significant differences in plasma proteins when comparing those children with and without pulmonary arteriovenous malformations (PAVMs) after superior cavopulmonary anastomosis (SCPA).

  • What does it add to the existing literature? The etiology of PAVMs in this population is likely due to factors other than, or in addition to, differences in plasma proteins. What is the impact? Further studies are needed to identify causes of PAVMs among children after SCPA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.

References

  1. Newburger, J. W. et al. Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial. Circulation 129, 2013–2020 (2014).

    Article  PubMed  PubMed Central  Google Scholar 

  2. d’Udekem, Y. et al. The Fontan procedure: contemporary techniques have improved long-term outcomes. Circulation 116, I157–I164 (2007).

    Article  PubMed  Google Scholar 

  3. Fontan, F. & Baudet, E. Surgical repair of tricuspid atresia. Thorax 26, 240–248 (1971).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Glenn, W. W. Circulatory bypass of the right side of the heart. IV. Shunt between superior vena cava and distal right pulmonary artery; report of clinical application. N. Engl. J. Med 259, 117–120 (1958).

    Article  CAS  PubMed  Google Scholar 

  5. Vettukattil, J. J. Is the Hepatic factor a miRNA that maintains the integrity of pulmonary microvasculature by inhibiting the vascular endothelial growth factor? Curr. Cardiol. Rev. 13, 244–250 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Shah, M. J., Rychik, J., Fogel, M. A., Murphy, J. D. & Jacobs, M. L. Pulmonary AV malformations after superior cavopulmonary connection: resolution after inclusion of hepatic veins in the pulmonary circulation. Ann. Thorac. Surg. 63, 960–963 (1997).

    Article  CAS  PubMed  Google Scholar 

  7. Srivastava, D. et al. Hepatic venous blood and the development of pulmonary arteriovenous malformations in congenital heart disease. Circulation 92, 1217–1222 (1995).

    Article  CAS  PubMed  Google Scholar 

  8. Kavarana, M. N. et al. Pulmonary artery endothelial cell phenotypic alterations in a large animal model of pulmonary arteriovenous malformations after the Glenn shunt. Ann. Thorac. Surg. 96, 1442–1449 (2013).

    Article  PubMed  PubMed Central  Google Scholar 

  9. Malhotra, S. P. et al. Superior cavopulmonary anastomosis suppresses the activity and expression of pulmonary angiotensin-converting enzyme. J. Thorac. Cardiovasc Surg. 122, 464–469 (2001).

    Article  CAS  PubMed  Google Scholar 

  10. Mumtaz, M. A. et al. Increased expression of vascular endothelial growth factor messenger RNA in lungs of rats after cavopulmonary anastomosis. J. Thorac. Cardiovasc Surg. 129, 209–210 (2005).

    Article  PubMed  Google Scholar 

  11. Chang, R. K. et al. Bubble contrast echocardiography in detecting pulmonary arteriovenous shunting in children with univentricular heart after cavopulmonary anastomosis. J. Am. Coll. Cardiol. 33, 2052–2058 (1999).

    Article  CAS  PubMed  Google Scholar 

  12. Stewart, M. J. Contrast echocardiography. Heart 89, 342–348 (2003).

    Article  PubMed  PubMed Central  Google Scholar 

  13. McSweeney, J. C. et al. Impact of the INBRE summer student mentored research program on undergraduate students in Arkansas. Adv. Physiol. Educ. 42, 123–129 (2018).

    Article  PubMed  Google Scholar 

  14. Chromatogram libraries improve peptide detection and quantification by data independent acquisition mass spectrometry. Available from: https://www.nature.com/articles/s41467-018-07454-w.

  15. Chawade, A., Sandin, M., Teleman, J., Malmstrom, J. & Levander, F. Data processing has major impact on the outcome of quantitative label-free LC-MS analysis. J. Proteome Res 14, 676–687 (2015).

    Article  CAS  PubMed  Google Scholar 

  16. Huber, W., von Heydebreck, A., Sultmann, H., Poustka, A. & Vingron, M. Variance stabilization applied to microarray data calibration and to the quantification of differential expression. Bioinformatics 18, S96–S104 (2002).

    Article  PubMed  Google Scholar 

  17. Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res 43, e47 (2015).

    Article  PubMed  PubMed Central  Google Scholar 

  18. Marshall, B., Duncan, B. W. & Jonas, R. A. The role of angiogenesis in the development of pulmonary arteriovenous malformations in children after cavopulmonary anastomosis. Cardiol. Young-.-. 7, 370–374 (1997).

    Article  Google Scholar 

  19. Ikai, A. et al. Hypoxic pulmonary vasoconstriction disappears in a rabbit model of cavopulmonary shunt. J. Thorac. Cardiovasc. Surg. 127, 1450–1457 (2004).

    Article  PubMed  Google Scholar 

  20. Malhotra, S. P. et al. Cavopulmonary anastomosis induces pulmonary expression of the angiotensin II receptor family. J. Thorac. Cardiovasc. Surg. 123, 655–660 (2002).

    Article  CAS  PubMed  Google Scholar 

  21. Field-Ridley, A. et al. Endostatin, an inhibitor of angiogenesis, decreases after bidirectional superior cavopulmonary anastamosis. Pediatr. Cardiol. 34, 291–295 (2013).

    Article  PubMed  Google Scholar 

  22. Hoffman, J. I. Normal and abnormal pulmonary arteriovenous shunting: occurrence and mechanisms. Cardiol. Young. 23, 629–641 (2013).

    Article  PubMed  Google Scholar 

  23. Bartoli, C. R., Hennessy-Strahs, S., Dowling, R. D., Gaynor, J. W. & Glatz, A. C. Abnormalities in the von Willebrand-Angiopoietin axis contribute to dysregulated angiogenesis and angiodysplasia in children with a Glenn circulation. Basic Transl. Sci. 6, 222–235 (2021).

    Google Scholar 

  24. Shirali, A. S. et al. Angiopoietin-2 predicts morbidity in adults with Fontan physiology. Sci. Rep. 9, 18328 (2019).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  25. Spearman, A. D. et al. sVEGFR1 is enriched in hepatic vein blood—Evidence for a provisional hepatic factor candidate? Front. Pediatr. 9, 679572 (2021).

    Article  PubMed  PubMed Central  Google Scholar 

  26. Vettukattil, J. J. Is the hepatic factor A miRNA that maintains the integrity of pulmonary microvasculature by inhibiting the vascular endothelial growth factor? Curr. Cardiol. Rev. 13, 244–250 (2017).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. Tamura, K. et al. Insulin-like growth factor binding protein-7 (IGFBP7) blocks vascular endothelial cell growth factor (VEGF)-induced angiogenesis in human vascular endothelial cells. Eur. J. Pharmacol. 610, 61–67 (2009).

    Article  CAS  PubMed  Google Scholar 

  28. Albig, A. R. & Schiemann, W. P. Fibulin-5 antagonizes vascular endothelial growth factor (VEGF) signaling and angiogenic sprouting by endothelial cells. DNA cell Biol. 23, 367–379 (2004).

    Article  CAS  PubMed  Google Scholar 

  29. Ohye, R. G., Schranz, D. & D’Udekem, Y. Current therapy for hypoplastic left heart syndrome and related single ventricle lesions. Circulation 134, 1265–1279 (2016).

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Funding

The present study was funded by a grant from the Arkansas Biosciences Institute.

Author information

Authors and Affiliations

Authors

Contributions

Substantial contributions to conception and design, acquisition of data, and analyzes/interpretation of data were performed by EHB, PMM, SDB, SGM, AMD, MJA, DZ, LEG, GMS, HZ, GTR. The article was drafted by EHB, and was critically reviewed for important intellectual content by PMM and SDB. All authors gave their final approval of the version submitted for publication.

Corresponding author

Correspondence to Elijah H. Bolin.

Ethics declarations

Competing interests

The authors declare no competing interests.

Consent statement

The present study was approved by the Institutional Review Board at the University of Arkansas for Medical Sciences, and informed consent was obtained from all patients; additionally, assent was obtained when appropriate for patients who were able to provide it.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Bolin, E.H., Mourani, P.M., Byrum, S.D. et al. Quantitative plasma proteomic analysis in children after superior cavopulmonary anastomosis with pulmonary arteriovenous malformations. Pediatr Res (2024). https://doi.org/10.1038/s41390-024-03450-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1038/s41390-024-03450-7

Search

Quick links